Nicholle E. Lewis, Troy Q. Tabarestani, Brianna R. Cellini, Nina Zhang, Eric J. Marrotte, Haichen Wang, Daniel T. Laskowitz, Muhammad M. Abd-El-Barr, Timothy D. Faw
Neurospine 2022;19(3):671-686. Published online September 30, 2022
Physical rehabilitation is essential for enhancing recovery in individuals with spinal cord injury (SCI); however, aside from early surgical intervention and hemodynamic management, there are no proven interventions for promoting recovery in the acute phase. In general, early rehabilitation is considered beneficial, but optimal parameters and potential contraindications for implementing rehabilitation at very early time points are unclear. Moreover, clinical trials to date are limited to studies initiating rehabilitation 2 weeks after injury and later. To address these gaps, this article reviews the preclinical literature on physical interventions initiated within the first 8 days postinjury. Effects of early rehabilitation on molecular and structural nervous system changes, behavioral function, and body systems are considered. Most studies utilized treadmill or cycle training as the primary intervention. Treadmill training initiated within the first 3 days and terminated by 1 week after injury worsened autonomic function, inflammation, and locomotor outcomes, while swim training during this period increased microvascular dysfunction. In contrast, lower-intensity rehabilitation such as reach training, ladder training, or voluntary wheel or ball training showed benefits when implemented during the first 3 days. Rehabilitation initiated at 4 days postinjury was also associated with enhanced motor recovery. Cycling appears to have the greatest risk-benefit ratio; however, the effects of cycle training in the first 3 days were not investigated. Overall, research suggests that lower intensity or voluntary rehabilitation during the hyperacute phase is more appropriate until at least 4 days postinjury, at which point higher-intensity activity becomes safer and more beneficial for recovery.
Citations
Citations to this article as recorded by
Evaluation of blood flow restriction combined with routine rehabilitation in incomplete thoracic and lumbar spinal cord injury after decompression: a retrospective study Guihua Xiao, Yonggang Zhu, Zhou Yang, Minxing Wang, Yegai Feng, Xueliang Xu, Yongxue Li European Spine Journal.2026; 35(2): 997. CrossRef
Therapeutic alliance in spinal cord injury rehabilitation: power, institutions, and disabling control Esha Lovrić, Niki Edwards, Julie King Physiotherapy Theory and Practice.2026; : 1. CrossRef
Long-term safety and clinical outcomes from a single-site phase 1 study of neural stem cell transplantation for chronic cervical spinal cord injury Mickey E. Abraham, Joel R. Martin, Margaret Seaton, Michael G. Brandel, Kiefer J. Forseth, Catriona Jamieson, Martin Marsala, Joseph D. Ciacci Stem Cell Reports.2026; : 102926. CrossRef
“White Cord Syndrome” as clinical manifestation of the spinal cord reperfusion syndrome: a systematic review of risk factors, treatments, and outcome Sadegh Bagherzadeh, Mohsen Rostami, Mohammad Jafari, Faramarz Roohollahi European Spine Journal.2025; 34(1): 50. CrossRef
Mobilization in Neurocritical Care: Challenges and Opportunities Kristen Nobles, Kyle Cunningham, Brianna Fecondo, Susan M. Closs, Kathleen Donovan, Monisha A. Kumar Current Neurology and Neuroscience Reports.2025;[Epub] CrossRef
Innovative MXene/SilMA-Based Conductive Bioink for Three Dimensional Bioprinting of Neural Stem Cell Spheroids in Neural Tissue Engineering Yu-Chun Yeh, Pin-Yuan Chen, Ko-Ting Chen, I-Chi Lee ACS Applied Materials & Interfaces.2025; 17(7): 10402. CrossRef
Reawakening inflammation in the chronically injured spinal cord using lipopolysaccharide induces diverse microglial states Rebecca K. John, Sadie P. Vogel, Sameera Zia, Kelly V. Lee, Antoinette T. Nguyen, Abel Torres-Espin, Keith K. Fenrich, Carmen Ng, Emma K. A. Schmidt, Romana Vavrek, Pamela J. F. Raposo, Keira Smith, Karim Fouad, Jason R. Plemel Journal of Neuroinflammation.2025;[Epub] CrossRef
Enduring benefits of exercise after spinal cord injury: Insights from a case study Candace Vermaak, Lovemore Kunorozva African Journal of Disability.2025;[Epub] CrossRef
Regenerative rehabilitation: Mechanisms, clinical applications, and translational challenges Botao Tan, An Zhang, Lehua Yu Regenesis Repair Rehabilitation.2025; 1(4): 1. CrossRef
Timing of rehabilitation and pressure ulcers requiring treatment during acute hospitalization in patients with cervical spinal cord injuries Risa Yamauchi, Yusuke Sasabuchi, Shotaro Aso, Hideo Yasunaga Spinal Cord.2025; 63(10): 544. CrossRef
The Soleus H-Reflex as a Biomarker of Post-Injury Spasticity in Spinal Cord Injury: A Conceptual Pilot Study Héloise Bourgeois, Hélène Genet, Maureen MacMahon, Andréane Richard-Denis, Jean-Marc Mac-Thiong, Louis de Beaumont, Dorothy Barthelemy NeuroRehabilitation.2025; 57(3): 328. CrossRef
Therapeutic potential of luteolin-loaded poly(lactic-co-glycolic acid)/modified magnesium hydroxide microsphere in functional thermosensitive hydrogel for treating neuropathic pain So-Yeon Park, Joon Hyuk Jung, Da-Seul Kim, Jun-Kyu Lee, Byeong Gwan Song, Hae Eun Shin, Ji-Won Jung, Seung-Woon Baek, Seungkwon You, Inbo Han, Dong Keun Han Journal of Tissue Engineering.2024;[Epub] CrossRef
Early Mobilization in Neurocritical Care Kristen Nobles, Kiersten Norby, Kristina Small, Monisha A. Kumar Current Treatment Options in Neurology.2024; 26(2): 13. CrossRef
The effect of early mobilisation (< 14 days) on pathophysiological and functional outcomes in animals with induced spinal cord injury: a systematic review with meta-analysis Natalie Gray, Junaid Shaikh, Alison Cowley, Vicky Goosey-Tolfrey, Pip Logan, Nasir Quraishi, Vicky Booth BMC Neuroscience.2024;[Epub] CrossRef
Early rehabilitation after spinal cord injury: a scoping review protocol Florence Martinache, Adéla Foudhaïli, Bernard Vigué JBI Evidence Synthesis.2024; 22(9): 1875. CrossRef
Innovative Strategies in 3D Bioprinting for Spinal Cord Injury Repair Daniel Youngsuk Kim, Yanting Liu, Gyubin Kim, Seong Bae An, Inbo Han International Journal of Molecular Sciences.2024; 25(17): 9592. CrossRef
Modulation of the LIMK Pathway by Myricetin: A Protective Strategy Against Neurological Impairments in Spinal Cord Injury Abhishek Roy, Santimoy Sen, Rudradip Das, Amit Shard, Hemant Kumar Neurospine.2024; 21(3): 878. CrossRef
Synergistic effects of curcumin and stem cells on spinal cord injury: a comprehensive review Reza Arefnezhad, Arian Jahandideh, Mahdi Rezaei, Mohamad Salehi Khatouni, Hooman Zarei, Saleheh Jahani, Ali Molavi, Mohammadhossein Hefzosseheh, Parisa Ghasempour, Hadis Moazen Movahedi, Romina Jahandideh, Fatemeh Rezaei-Tazangi Molecular Biology Reports.2024;[Epub] CrossRef
A dynamic nomogram for predicting the probability of irreversible neurological dysfunction after cervical spinal cord injury: research based on clinical features and MRI data Si Chen, Guangzhou Li, Feng Li, Gaoju Wang, Qing Wang BMC Musculoskeletal Disorders.2023;[Epub] CrossRef
Objective Acute spinal cord injury (SCI) can result in debilitating motor, sensory, and autonomic dysfunction. As a treatment option, therapeutic hypothermia has been researched to inadequate pharmaceutical treatment, except for methylprednisolone. In this article, we systematically meta-analyzed to clarify the effect of hypothermia in acute SCI on neurological outcomes.
Methods The PubMed, Embase, Web of Science, and Cochrane clinical trial databases were systematically searched until June 30, 2022. The proportion of cases with improved neurological status after hypothermia in acute SCI were pooled with a random-effects model. Subgroup analyses for the method of hypothermia and injury level were conducted.
Results Eight studies with a total of 103 patients were included. Hypothermia in acute SCI improved neurological function by 55.8% (95% confidence interval [CI]: 39.4%–72.1%). The subgroup analysis revealed that the pooled proportion of cases showing neurological improvement was higher with systemic hypothermia (70.9%) (95% CI, 14.9%–100%) than with local hypothermia (52.5%) (95% CI, 40.4%–64.5%), although the subgroup difference was not statistically significant (p = 0.53). Another subgroup analysis revealed that the proportion of cases with neurological improvement did not differ statistically between the cervical spine (61.4%) (95% CI, 42.2%–80.6%) and thoracic spine injury groups (59.4%) (95% CI, 34.8%–84.0%) (p = 0.90).
Conclusion This meta-analysis identified that more than 50% of patients showed neurological improvement after hypothermia following acute SCI in general. A multicenter, randomized, double-blind study with larger sample size is necessary to validate the findings further.
Citations
Citations to this article as recorded by
Current and emergent therapies targeting spinal cord injury Giovanni Grasso, Luigi Cusimano, Manfredi Noto, Rosario Maugeri, Domenico Gerardo Iacopino Brain and Spine.2025; 5: 104243. CrossRef
Traumatic Spinal Cord Injury: Review of the Literature Lori Zarmer, Maaz Khan, Glenn Islat, Hanan Alameddin, Maria Massey, Rabail Chaudhry Journal of Clinical Medicine.2025; 14(11): 3649. CrossRef
The future of artificial hibernation medicine Caiyun Liu, Haixin Yu, Zhengchao Li, Shulian Chen, Xiaoyin Li, Xuyi Chen, Bo Chen Neural Regeneration Research.2024; 19(1): 22. CrossRef
Clinical Assessment and Management of Acute Spinal Cord Injury Christian Quinones, John Preston Wilson, Deepak Kumbhare, Bharat Guthikonda, Stanley Hoang Journal of Clinical Medicine.2024; 13(19): 5719. CrossRef
Co-Administration of Resolvin D1 and Peripheral Nerve-Derived Stem Cell Spheroids as a Therapeutic Strategy in a Rat Model of Spinal Cord Injury Seung-Young Jeong, Hye-Lan Lee, SungWon Wee, HyeYeong Lee, GwangYong Hwang, SaeYeon Hwang, SolLip Yoon, Young-Il Yang, Inbo Han, Keung-Nyun Kim International Journal of Molecular Sciences.2023; 24(13): 10971. CrossRef
Commentary on “Different Ways to Die: Cell Death Pathways and Their Association With Spinal Cord Injury” Jeffrey Luo, Joshua B. Stein, Ki-Bum Lee Neurospine.2023; 20(2): 449. CrossRef
Early surgical intervention for acute spinal cord injury: time is spine Ayesha Quddusi, Karlo M. Pedro, Mohammed Ali Alvi, Nader Hejrati, Michael G. Fehlings Acta Neurochirurgica.2023; 165(9): 2665. CrossRef
Acute spinal cord injury (SCI) is devastating for patients and their caretakers and has an annual incidence of 20–50 per million people. Following initial assessment with appropriate physical examination and imaging, patients who are deemed surgical candidates should undergo decompression with stabilization. Earlier intervention can improve neurological recovery in the post-operative period while allowing earlier mobilization. Optimized medical management is paramount to improve outcomes. Emerging strategies for managing SCI in the acute period stem from an evolving understanding of the pathophysiology of the injury. General areas of focus include ischemia prevention, reduction of secondary injury due to inflammation, modulation of the cytotoxic and immune response, and promotion of cellular regeneration. In this article, we review established, emerging, and novel experimental therapies. Continued translational research on these methods will improve the feasibility of bench-to-bedside innovations in treating patients with acute SCI.
Citations
Citations to this article as recorded by
The role of autophagy in spinal cord injury: Mechanisms, crosstalk, and therapeutic strategies Rui Wang, Zhen Niu, Runze Tian, Aini Chen, Huangmei Liao, Rui Kuang, Ying Feng, Guangyu Chin, Jiesheng Xie, Ping Zhu, Chi Teng Vong, Ge Li Neural Regeneration Research.2026; 21(6): 2110. CrossRef
The Interplay Between Neuromodulation and Stem Cell Therapy for Sensory-Motor Neuroplasticity After Spinal Cord Injury: A Perspective View Anthony Yousak, Kaci Ann Jose, Ashraf S. Gorgey Journal of Clinical Medicine.2026; 15(2): 879. CrossRef
Automated active learning to optimize hydrogel drug release profiles Eugene Cheong, D. Christopher Radford, Adam J. Gormley Journal of Controlled Release.2026; 391: 114602. CrossRef
Andrograpanin attenuates secondary neuroinflammation after spinal cord injury by modulating microglial glycolysis via HIF-1α Bin Dai, Xintian Ding, Kaichen Huang, Jiahao Ruan, Jiafeng Peng, Hongxing Zhang, Dapeng Li International Immunopharmacology.2026; 182: 116796. CrossRef
Autonomic dysreflexia: the concealed killer behind recurrent cerebral hemorrhage in spinal cord injury—a case report with management insights Nengzhang Tang, Bi'e Zheng, Jun Ni, Yimiao Xie, Lifang Zhang, Qiong Han, Limin Sun Frontiers in Neuroscience.2026;[Epub] CrossRef
Roflumilast inhibits neuronal ferroptosis via AMPK/Nrf2/HO-1 signaling and promotes motor function recovery after spinal cord injury in rats YaoNan Han, XingTong Wang, DeShui Yu Cellular Signalling.2025; 134: 111930. CrossRef
Bibliometric Analysis of Exosome Research in Spinal Cord Injury (2000–May 2024). Trends, Collaborations, and Emerging Insights Zhihua Wang, Hangchuan Bi, Denghui Li, Wan Zhang, Chao Wang, Jianyi Yang, Xianglin Shen, Rongji Yan, Fei He, Hao Duan Drug Design, Development and Therapy.2025; Volume 19: 6829. CrossRef
Therapeutic potential of luteolin-loaded poly(lactic-co-glycolic acid)/modified magnesium hydroxide microsphere in functional thermosensitive hydrogel for treating neuropathic pain So-Yeon Park, Joon Hyuk Jung, Da-Seul Kim, Jun-Kyu Lee, Byeong Gwan Song, Hae Eun Shin, Ji-Won Jung, Seung-Woon Baek, Seungkwon You, Inbo Han, Dong Keun Han Journal of Tissue Engineering.2024;[Epub] CrossRef
Morphogenetic Designs, and Disease Models in Central Nervous System Organoids Minsung Bock, Sung Jun Hong, Songzi Zhang, Yerin Yu, Somin Lee, Haeeun Shin, Byung Hyune Choi, Inbo Han International Journal of Molecular Sciences.2024; 25(14): 7750. CrossRef
Innovative Strategies in 3D Bioprinting for Spinal Cord Injury Repair Daniel Youngsuk Kim, Yanting Liu, Gyubin Kim, Seong Bae An, Inbo Han International Journal of Molecular Sciences.2024; 25(17): 9592. CrossRef
Modulation of the LIMK Pathway by Myricetin: A Protective Strategy Against Neurological Impairments in Spinal Cord Injury Abhishek Roy, Santimoy Sen, Rudradip Das, Amit Shard, Hemant Kumar Neurospine.2024; 21(3): 878. CrossRef
Minocycline as Potential Neuroprotector through Neuroinflammation Halting Mechanism in Spinal Cord Injury: Literature Review Kevin Tjandra Neurologico Spinale Medico Chirurgico.2024; 7(2): 69. CrossRef
Edema after CNS Trauma: A Focus on Spinal Cord Injury Mostafa Seblani, Patrick Decherchi, Jean-Michel Brezun International Journal of Molecular Sciences.2023; 24(8): 7159. CrossRef
Recent updates in autonomic research: advances in the understanding of autonomic dysfunction after spinal cord injury Vera-Ellen M. Lucci Clinical Autonomic Research.2023; 33(2): 83. CrossRef
Commentary on “Different Ways to Die: Cell Death Pathways and Their Association With Spinal Cord Injury” Jeffrey Luo, Joshua B. Stein, Ki-Bum Lee Neurospine.2023; 20(2): 449. CrossRef
Different Ways to Die: Cell Death Pathways and Their Association With Spinal Cord Injury Lahanya Guha, Nidhi Singh, Hemant Kumar Neurospine.2023; 20(2): 430. CrossRef
Commentary on “Established and Emerging Therapies in Acute Spinal Cord Injury” Lingbo Kong Neurospine.2022; 19(2): 297. CrossRef
A Nomogram Model for Prediction of Tracheostomy in Patients With Traumatic Cervical Spinal Cord Injury Yunbo Jian, Dawei Sun, Zhengfeng Zhang Neurospine.2022; 19(4): 1084. CrossRef
Therapeutic Approaches Targeting Vascular Repair After Experimental Spinal Cord Injury: A Systematic Review of the Literature Laurens Roolfs, Vanessa Hubertus, Jacob Spinnen, Lennard K. Shopperly, Michael G. Fehlings, Peter Vajkoczy Neurospine.2022; 19(4): 961. CrossRef
This is a review article examining the pharmacologic and regenerative cell therapy for spinal cord injury. A literature search during last 10 years were conducted using key words. Case reports, experimental (nonhuman) studies, papers other than English language were excluded. Up-to-date information on the pharmacologic and regenerative cell therapy for spinal cord injury was reviewed and statements were produced to reach a consensus in 2 separate consensus meeting of WFNS Spine Committee. The statements were voted and reached a consensus using Delphi method. Pharmacologic and regenerative cell therapy for spinal cord injury have long been an interest of many experimental and clinical researches. Clinical studies with methylpredinisolone have not shown clear cut benefit. Other drugs such as Rho inhibitor, minocycline, riluzole, granulocyte colony-stimulating factor have also been tried without significant benefits. Regenerative cell therapy using different types of stem cells, different inoculation techniques, and scaffolds have undergone many trials highlighting the efficacies of cells and their limitations. This review article summarizes the current knowledge on pharmacologic and regenerative cell therapy for spinal cord injury. Unfortunately, there is a need for further experimental and human trials to recommend effective pharmacologic and regenerative cell therapy.
Citations
Citations to this article as recorded by
Characteristics of Parthenogenetic Stem Cells and Their Potential Treatment Strategy for Central Nervous System Diseases Hengsen Cai, Jiajun Huang, Wei Wang, Wentong Lin, Waqas Ahmed, Deng Lu, Jiewei Quan, Lukui Chen Neuropsychiatric Disease and Treatment.2025; Volume 21: 213. CrossRef
Additive manufacturing in spatial patterning for spinal cord injury treatment Christy Kwokdinata, Sing Yian Chew Advanced Drug Delivery Reviews.2025; 218: 115523. CrossRef
Pectin-Zein-IPA nanoparticles promote functional recovery and alleviate neuroinflammation after spinal cord injury Xianghang Chen, Beini Wang, Abdullah Al Mamun, Kaiyi Du, Shengfu Wang, Qianqian Hu, Xinyuan Chen, Yang Lu, Anyu Du, Yueqi Wu, Jiaqin Shao, Shuangshuang Wang, Chang Jiang, Kailiang Zhou, Siwang Hu, Jian Xiao Journal of Nanobiotechnology.2025;[Epub] CrossRef
BOOTStrap-SCI: Beyond One Option of Treatment for Spinal Trauma and Spinal Cord Injury: Consensus-Based Stratified Protocols for Intensive Care and Surgical Management Nicolò Marchesini, Riya Mandar Dange, Andreas K. Demetriades, Oscar Alves, Amos Olufemi Adeleye, Ernest J. Barthélemy, José Castillo, Juan Diego Ciro, Raul Echeverri, Kiwon Lee, Wellingson Paiva, Julio Pozuelos, Martin Aliaga Rocabado, Alvaro Soto, Gene Y World Neurosurgery.2025; 200: 124099. CrossRef
LncRNA TSIX knockdown restores spinal cord injury repair through miR-30a/SOCS3 axis Zhimin Pan, Kai Huang, Nan Li, Pingguo Duan, Jiang Huang, Dong Yang, Zujue Cheng, Yoon Ha, Jinsoo Oh, Mengyun Yue, Xingen Zhu, Da He Biotechnology and Genetic Engineering Reviews.2024; 40(2): 765. CrossRef
Epidemiological and clinical features, treatment status, and economic burden of traumatic spinal cord injury in China: a hospital-based retrospective study Hengxing Zhou, Yongfu Lou, Lingxiao Chen, Yi Kang, Lu Liu, Zhiwei Cai, David B. Anderson, Wei Wang, Chi Zhang, Jinghua Wang, Guangzhi Ning, Yanzheng Gao, Baorong He, Wenyuan Ding, Yisheng Wang, Wei Mei, Yueming Song, Yue Zhou, Maosheng Xia, Huan Wang, Jie Neural Regeneration Research.2024; 19(5): 1126. CrossRef
Stem Cell and Regenerative Therapies for the Treatment of Osteoporotic Vertebral Compression Fractures Songzi Zhang, Yunhwan Lee, Yanting Liu, Yerin Yu, Inbo Han International Journal of Molecular Sciences.2024; 25(9): 4979. CrossRef
Promotion of Bone Formation in a Rat Osteoporotic Vertebral Body Defect Model via Suppression of Osteoclastogenesis by Ectopic Embryonic Calvaria Derived Mesenchymal Stem Cells Yerin Yu, Somin Lee, Minsung Bock, Seong Bae An, Hae Eun Shin, Jong Seop Rim, Jun-oh Kwon, Kwang-Sook Park, Inbo Han International Journal of Molecular Sciences.2024; 25(15): 8174. CrossRef
Innovative Strategies in 3D Bioprinting for Spinal Cord Injury Repair Daniel Youngsuk Kim, Yanting Liu, Gyubin Kim, Seong Bae An, Inbo Han International Journal of Molecular Sciences.2024; 25(17): 9592. CrossRef
Predicting the Role of Preoperative Intramedullary Lesion Length and Early Decompressive Surgery in ASIA Impairment Scale Grade Improvement Following Subaxial Traumatic Cervical Spinal Cord Injury Raj Kamal, Himanshu Verma, Sunil Narasimhaiah, Suruchi Chopra Journal of Neurological Surgery Part A: Central European Neurosurgery.2023; 84(02): 144. CrossRef
A critical appraisal of clinical practice guidelines on pharmacological treatments for spinal cord injury Bin Guan, Yuxuan Fan, Ruiyuan Zheng, Runhan Fu, Liang Yao, Wei Wang, Guoyu Li, Lingxiao Chen, Hengxing Zhou, Shiqing Feng The Spine Journal.2023; 23(3): 392. CrossRef
Transplantation of Wnt4‐modified neural stem cells mediate M2 polarization to improve inflammatory micro‐environment of spinal cord injury Baiqi Pan, Xiaoyu Wu, Xiaolin Zeng, Jiewen Chen, Wenwu Zhang, Xing Cheng, Yong Wan, Xiang Li Cell Proliferation.2023;[Epub] CrossRef
The course of complicated injury of the cervical spine with the development of neurogenic shock M. N. Lebedeva, I. A. Statsenko, A. V. Palmash, E. Yu. Ivanova, V. V. Rerikh Hirurgiâ pozvonočnika (Spine Surgery).2023; 20(1): 43. CrossRef
Multimodal therapy strategy based on a bioactive hydrogel for repair of spinal cord injury Eun Ji Roh, Da-Seul Kim, Jun Hyuk Kim, Chang Su Lim, Hyemin Choi, Su Yeon Kwon, So-Yeon Park, Jun Yong Kim, Hyun-Mun Kim, Dong-Youn Hwang, Dong Keun Han, Inbo Han Biomaterials.2023; 299: 122160. CrossRef
Regulatory Role of Mesenchymal Stem Cells on Secondary Inflammation in Spinal Cord Injury Qi-Ming Pang, Si-Yu Chen, Sheng-Ping Fu, Hui Zhou, Qian Zhang, Jun Ao, Xiao-Ping Luo, Tao Zhang Journal of Inflammation Research.2022; Volume 15: 573. CrossRef
Fabrication Techniques of Nerve Guidance Conduits for Nerve Regeneration Nae-Un Kang, Seung-Jae Lee, So-Jung Gwak Yonsei Medical Journal.2022; 63(2): 114. CrossRef
Early Stages Management of Traumatic Spinal Cord Injury in Latin America: A Scoping Review Nicolò Marchesini, Laura Lucía Fernández Londoño, Dylan Griswold, Andrés Mariano Rubiano World Neurosurgery.2022; 162: 138. CrossRef
Clinical Trials Using Mesenchymal Stem Cells for Spinal Cord Injury: Challenges in Generating Evidence Lila Teixeira de Araújo, Carolina Thé Macêdo, Patrícia Kauanna Fonseca Damasceno, Ítalo Gabriel Costa das Neves, Carla Souza de Lima, Girlaine Café Santos, Thaís Alves de Santana, Gabriela Louise de Almeida Sampaio, Daniela Nascimento Silva, Cristiane Flo Cells.2022; 11(6): 1019. CrossRef
Established and Emerging Therapies in Acute Spinal Cord Injury Ron Gadot, David N. Smith, Marc Prablek, Joey K. Grochmal, Alfonso Fuentes, Alexander E. Ropper Neurospine.2022; 19(2): 283. CrossRef
Commentary on “The Role of Alginate Hydrogels as a Potential Treatment Modality for Spinal Cord Injury: A Comprehensive Review of the Literature” Hemant Kumar Neurospine.2022; 19(2): 281. CrossRef
The immune microenvironment and tissue engineering strategies for spinal cord regeneration Yuan Feng, Yong Peng, Jing Jie, Yumin Yang, Pengxiang Yang Frontiers in Cellular Neuroscience.2022;[Epub] CrossRef
Exploring perspectives and adherence to guidelines for adult spinal trauma in low and middle-income healthcare economies: A survey on barriers and possible solutions (part I) Nicolò Marchesini, Andreas K. Demetriades, Oscar L. Alves, Francesco Sala, Andrés M. Rubiano Brain and Spine.2022; 2: 100932. CrossRef
Secondary damage management of acute traumatic spinal cord injury in low and middle-income countries: A survey on a global scale (Part III) Nicolò Marchesini, Andrés M. Rubiano, Francesco Sala, Andreas K. Demetriades, Oscar L. Alves Brain and Spine.2022; 2: 101694. CrossRef
Management of acute spinal cord injuries Sultan Mohammed Alanazi, Hatim Faihan Alotaibi, Ibrahim Mohammed Alanazi, Adel Mohammad Aldukhain, Rakan Faisal Albasri, Salman Abdullah Alharbi, Hamoud Ghayyadh Alanizi, Yussef Falah Alharbi, Diyanah Bander Almutairi, Aseel Hasson Alhasson, Alaa Ibrah International journal of health sciences.2022; 6(S10): 1816. CrossRef
Peripheral Nerve-Derived Stem Cell Spheroids Induce Functional Recovery and Repair after Spinal Cord Injury in Rodents Hye-Lan Lee, Chung-Eun Yeum, HyeYeong Lee, Jinsoo Oh, Jong-Tae Kim, Won-Jin Lee, Yoon Ha, Young-Il Yang, Keung-Nyun Kim International Journal of Molecular Sciences.2021; 22(8): 4141. CrossRef
Bazedoxifene, a Selective Estrogen Receptor Modulator, Promotes Functional Recovery in a Spinal Cord Injury Rat Model Yiyoung Kim, Eun Ji Roh, Hari Prasad Joshi, Hae Eun Shin, Hyemin Choi, Su Yeon Kwon, Seil Sohn, Inbo Han International Journal of Molecular Sciences.2021; 22(20): 11012. CrossRef
First
Prev
